Abstract
Tumour cell death can be evaluated in the living mouse by externally measuring the rate of loss of tumour-bound DNA tracer. By sequentially labelling the tumour-bearing animals with 125IUdR and 131IUdR 50 h apart, the average tumour cells at the time of the second injection are labelled by 125IUdR and the euoxic tumour cells are specifically labelled with 131IUdR. Tumour treatment at this stage of labelling permits the observation of the reaction of euoxic cells and average tumour cells and finally yields data on hypoxic cells and thus on the oxygen enhancement ratio. This information adds to results from tumour control and growth delay.
With this technique effects were analysed of 60-Co γ-rays, cyclotron neutrons (E = 6 MeV), misonidazole (500 mg/kg body wt) and hyperthermia (42°C water-bath), or combinations of these.
Misonidazole (15 min before irradiation) altered the oxygen enhancement ratio by a factor of 1·5 for γ-rays and of 1·1 for neutrons; when evaluated from tumour-growth delay and TCD-50 misonidazole gave a dose modifying factor of 1·47 for γ-rays and of 1·2-1·3 for neutrons.
Based on percentage tumour regression 100 days after treatment, the enhancement ratio from hyperthermia (after irradiation) was 2·75 for γ-rays (at 10 Gray) and 2·2 for neutrons (at 3·2 Gray). For neutrons combined with misonidazole and hyperthermia the ratio was 2·4.
These results demonstrate that effects of neutron irradiation may be modified by electron-affinic substances and/or hyperthermia.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bosiljanoff P., Porschen W., Piepenbring W., Mühlensiepen H., Feinendegen L. E. In-vivo-Untersuchungen über die relative Strahlenempfindlichkeit hypoxischer Tumorzellen. Strahlentherapie. 1977 Mar;153(3):178–189. [PubMed] [Google Scholar]
- Porschen W., Feinendegen L. In-vivo-Bestimmung der Zellverlustrate bei Experimentaltumoren mit markiertem Joddeoxyuridin. Strahlentherapie. 1969 Jun;137(6):718–723. [PubMed] [Google Scholar]